KLC

KinderCare is a paradox: the income statement looks broken while the cash statement looks healthy. FY2026 revenue rose 2.6% to $2.73B (helped by a 53rd week that added $45.1M), yet the company reported a $113M net loss and a -$20.1M operating loss. Crucially, that GAAP loss is dominated by one-time IPO plumbing, not operations — management booked $113.1M of stock-based comp when it modified/accelerated its PIU and option plans at the October 2024 IPO, plus a $24.8M loss on debt extinguishment when it repaid $608M of first-lien term loan with the $616.1M in net proceeds. Strip those out and the operating business is a strong cash generator: operating cash flow doubled to $239M and capex was $128M, leaving roughly $111M of free cash flow against a $574M market cap — a ~19% FCF yield. Layered on P/S of 0.2x, the stock is priced as if the business is dying when the cash says otherwise.

The quality picture is more mixed than the cash flow alone suggests. Profitability has genuinely deteriorated across the cycle — net income went $219M (FY2022) → $103M (FY2023) → -$92.8M (FY2024) → -$113M (FY2026) — so this is not purely an IPO-year optical loss; ROE is -14.9% and retained earnings have flipped to a -$82.6M deficit. The balance sheet carries real leverage: $918M of long-term debt, liabilities/equity of 3.96x (inflated by capitalized leases on 1,600+ mostly-leased centers, including a master lease on ~500 centers running to 2033), and a current ratio of just 0.74 ($358M current assets vs $485M current liabilities). Cash more than doubled to $133M, which helps, but this is a thin-equity, lease-heavy operator with little margin for error if enrollment or labor costs turn.